Back to Safety topics

Latex-free medications

Premier's latex-free catalogs

Products and suppliers are under contract with Premier and are provided to assist Premier members with identification of products that are environmentally preferable or safety-related. Premier's Supply Chain Advisor should be consulted for detailed information on the products in each list.

Latex-safe emergency cart products list

This comprehensive site provides a complete list of latex items for an emergency cart, including a specific table addressing medications. Table 3 provides list of medications available in pre-filled syringes with non-latex plungers along with a list of medications available in latex-free vials, tubexes, syringes, and cartridges plungers. Emergency medications manufactured in vials with latex stoppers and the manufacturers are also contained in this list. View this list at:

http://www.anapsid.org/cnd/mcs/latex2.html

Latex drugs.com

This site permits the user to search for a drug and then lists the NDC number, manufacturer(s), generic name, brand name, strength, dosage forms, it includes a comments section and the date that drug was last reviewed. All information is supplied directly from pharmaceutical manufacturer documentation. The site contains over 2500 drug entries, and the annual subscription cost to retrieve the information is $180. View the database site:

http://www.latexdrugs.com

UKMiCentral

The National Health Service of the United Kingdom (UK) provides a database for health professionals needing the latex content of injectable medications. The site permits a search for a specific product, as well as list by generic name, trade name, company and whether or not it contains latex.  View this table, Latex content of commonly used injections:

http://www.ukmicentral.nhs.uk/

New Zealand Guidelines Group

The New Zealand, Guideline Group provides a list by medication, brand name and manufacturer as well as if it is known whether the medication contains latex. View this table, A Guideline to Assist in the Management of Those Patients Known, or Thought, to be at Risk of Suffering from an Allergy to Latex Containing Products and Appendix 1: Latex Content of Stoppers in Injectable Pharmaceutical Agents:

http://www.nzgg.org.nz/guidelines/dsp_guideline_popup.cfm?&guidelineID=43

Back to top

Home | Reducing Costs | Improving Quality & Safety | Managing Risk | About Premier